Severe Sinus Congestion Allergy And Cough Formula Capsule, Liquid Filled
NDC Package 51013-169-08
Package Information
Severe Sinus Congestion Allergy And Cough Formula (acetaminophen, dextromethorphan hydrobromide , doxylamine succinate, phenylephrine hydrochloride) capsules is do not take more than the recommended doseadults and children 12 years and over: take 2 softgelss with water every 4 hours. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Puracap Pharmaceutical Llc, this product is identified by NDC 51013-169 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1297288 - acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG / phenylephrine HCl 5 MG Oral Capsule
- RxCUI: 1297288 - acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule
- RxCUI: 1297288 - APAP 325 MG / Dextromethorphan Hydrobromide 10 MG / doxylamine succinate 6.25 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Antihistamine - [EPC] (Established Pharmacologic Class)
- Histamine Receptor Antagonists - [MoA] (Mechanism of Action)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 51013 - Puracap Pharmaceutical Llc
- 51013-169 - Severe Sinus Congestion Allergy And Cough Formula
- 51013-169-08 - 2 BLISTER PACK in 1 CARTON / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
- 51013-169 - Severe Sinus Congestion Allergy And Cough Formula
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51013-169-08 identifies a specific commercial package of 2 blister pack in 1 carton / 10 capsule, liquid filled in 1 blister pack of Severe Sinus Congestion Allergy And Cough Formula, a human over the counter drug labeled by Puracap Pharmaceutical Llc. This capsule, liquid filled is formulated for oral use and contains acetaminophen; dextromethorphan hydrobromide; doxylamine succinate; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Puracap Pharmaceutical Llc on June 29, 2016. The current certification is valid through December 31, 2026.
How is this Puracap Pharmaceutical Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51013016908. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.